Rigel Pharmaceuticals：拥有临床催化剂的四药公司 (NASDAQ:RIGL)
· seekingalpha.com
Rigel Pharmaceuticals 引进了用于治疗特定乳腺癌患者的药物 Veppanu，目标市场规模达 10 亿美元。阅读为何 RIGL 股票被评为“买入”。
Rigel Pharmaceuticals ( RIGL ) is now a four-drug company, with a clinical catalyst ahead for a potential fifth drug. When I wrote about RIGL in January, I rate...